Edition:
India

Axonics Modulation Technologies Inc (AXNX.OQ)

AXNX.OQ on NASDAQ Stock Exchange Global Select Market

39.62USD
12:48am IST
Change (% chg)

$2.64 (+7.14%)
Prev Close
$36.98
Open
$37.67
Day's High
$39.99
Day's Low
$37.31
Volume
80,839
Avg. Vol
239,882
52-wk High
$41.83
52-wk Low
$15.26

Latest Key Developments (Source: Significant Developments)

Axonics Says Public Offering Of 4 Mln Common Shares Priced At $32.50/Share
Friday, 8 May 2020 

May 7 (Reuters) - Axonics Modulation Technologies Inc ::AXONICS® ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 4.00 MILLION COMMON SHARES PRICED AT $32.50PER SHARE.  Full Article

Axonics Says Commenced Proposed Public Offering Of $100 Million In Shares
Friday, 8 May 2020 

May 7 (Reuters) - Axonics Modulation Technologies Inc ::AXONICS® ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.AXONICS MODULATION TECHNOLOGIES INC - COMMENCED A PROPOSED PUBLIC OFFERING OF $100 MILLION IN SHARES.  Full Article

Axonics Reports First Quarter 2020 Results
Wednesday, 6 May 2020 

May 5 (Reuters) - Axonics Modulation Technologies Inc ::AXONICS® REPORTS FIRST QUARTER 2020 RESULTS.Q1 REVENUE $26.3 MILLION VERSUS $1.1 MILLION.Q1 REVENUE ESTIMATE $14.6 MILLION -- REFINITIV IBES DATA.QTRLY LOSS PER SHARE $0.43.Q1 EARNINGS PER SHARE VIEW $-0.60 -- REFINITIV IBES DATA.  Full Article

Axonics Names Michael Carrel As Chairman Of Its Board Of Directors
Wednesday, 29 Apr 2020 

April 29 (Reuters) - Axonics Modulation Technologies Inc ::AXONICS NAMES MICHAEL H. CARREL AS CHAIRMAN OF ITS BOARD OF DIRECTORS.AXONICS MODULATION TECHNOLOGIES - RAPHAEL WISNIEWSKI IS RETIRING AND WILL NOT STAND FOR RE-ELECTION AT 2020 ANNUAL MEETING OF STOCKHOLDERS.  Full Article

Axonics Modulation Says Most Employees To Take Temporary 20% Cut In Base Salary For Remainder Of Q2 2020
Friday, 17 Apr 2020 

April 16 (Reuters) - Axonics Modulation Technologies Inc ::AXONICS MODULATION TECHNOLOGIES INC - MOST EMPLOYEES WILL BE TAKING TEMPORARY 20% CUT IN BASE SALARY FOR REMAINDER OF Q2 2020 DUE TO COVID-19 IMPACT.AXONICS MODULATION TECHNOLOGIES - BASE SALARY CUTS INCLUDE 20% CUT FOR CEO AND ALL NAMED EXECUTIVE OFFICERS, WORLDWIDE SALES AND CLINICAL PERSONNEL.AXONICS MODULATION TECHNOLOGIES INC - CERTAIN MANUFACTURING EMPLOYEES AT LOWER END OF CO'S COMPENSATION RANGE WILL GET A 10% INCREASE IN HOURLY WAGES.AXONICS MODULATION TECHNOLOGIES INC - FOR Q2 OF 2020, CASH RETAINER FOR EACH DIRECTOR SERVING ON BOARD WILL ALSO BE TEMPORARILY REDUCED BY 20%.  Full Article

Axonics® Says U.S. FDA Approves Implantable Neurostimulator
Tuesday, 14 Apr 2020 

April 14 (Reuters) - Axonics Modulation Technologies Inc ::AXONICS® ANNOUNCES U.S. FOOD & DRUG ADMINISTRATION APPROVAL OF NEXT GENERATION IMPLANTABLE NEUROSTIMULATOR.AXONICS MODULATION TECHNOLOGIES INC - NEXT GENERATION AXONICS INS IS EXPECTED TO BEGIN SHIPPING TO CUSTOMERS IN U.S. DURING Q3 OF 2020.  Full Article

James Flynn Reports 5.23% Passive Stake In Axonics Modulation Technologies Inc As Of March 13
Wednesday, 25 Mar 2020 

March 24 (Reuters) - James Flynn :JAMES FLYNN REPORTS 5.23% PASSIVE STAKE IN AXONICS MODULATION TECHNOLOGIES INC AS OF MARCH 13 - SEC FILING.  Full Article

Axonics Announces Filing Of Petitions Before The U.S. Patent And Trademark Office
Monday, 16 Mar 2020 

March 16 (Reuters) - Axonics Modulation Technologies Inc ::AXONICS® ANNOUNCES FILING OF PETITIONS BEFORE THE UNITED STATES PATENT AND TRADEMARK OFFICE CONTESTING THE VALIDITY OF MEDTRONIC PATENTS.AXONICS- FILING SEVEN PETITIONS BEFORE USPTO REQUESTING INTER PARTES REVIEW TO CONTEST VALIDITY OF PATENTS MEDTRONIC HAS ALLEGED TO BE INFRINGED BY CO.  Full Article

Axonics Beats Qtrly Revenue Estimates
Thursday, 5 Mar 2020 

March 4 (Reuters) - Axonics Modulation Technologies Inc ::AXONICS® ANNOUNCES FOURTH QUARTER AND FISCAL 2019 FINANCIAL RESULTS.Q4 REVENUE $9.9 MILLION VERSUS $500,000.Q4 REVENUE ESTIMATE $5.8 MILLION -- REFINITIV IBES DATA.  Full Article

Axonics Announces FDA Approval Of Enhanced Neurostimulator Programmer
Tuesday, 21 Jan 2020 

Jan 21 (Reuters) - Axonics Modulation Technologies Inc ::AXONICS® ANNOUNCES FDA APPROVAL OF ENHANCED NEUROSTIMULATOR PROGRAMMER.AXONICS MODULATION TECHNOLOGIES - FDA APPROVAL OF ENHANCED, SECOND-GENERATION PROGRAMMER FOR ITS R-SNM SYSTEM UNDER A PMA APPLICATION SUPPLEMENT.  Full Article

BRIEF-Axonics Receives FDA Approval for 3T Full-Body MRI Scans

* AXONICS® RECEIVES FDA APPROVAL FOR 3T FULL-BODY MRI SCANS Source text for Eikon: Further company coverage: